These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 10925114)
1. Evidence for elevated telomerase activity in small cell carcinoma of the bladder. Selli C; Gelmini S; Scott CA; Crisci A; Giannarini G; Orlando C Urology; 2000 Aug; 56(2):331. PubMed ID: 10925114 [TBL] [Abstract][Full Text] [Related]
2. Comparison of telomerase activity in bladder carcinoma and exfoliated cells collected in urine and bladder washings, using a quantitative assay. Gelmini S; Crisci A; Salvadori B; Pazzagli M; Selli C; Orlando C Clin Cancer Res; 2000 Jul; 6(7):2771-6. PubMed ID: 10914723 [TBL] [Abstract][Full Text] [Related]
3. Detection of telomerase activity in exfoliated cells in urine from patients with bladder cancer. Kinoshita H; Ogawa O; Kakehi Y; Mishina M; Mitsumori K; Itoh N; Yamada H; Terachi T; Yoshida O J Natl Cancer Inst; 1997 May; 89(10):724-30. PubMed ID: 9168188 [TBL] [Abstract][Full Text] [Related]
4. Semi-quantitative analysis of telomerase activity in exfoliated human urothelial cells and bladder transitional cell carcinoma. Yokota K; Kanda K; Inoue Y; Kanayama H; Kagawa S Br J Urol; 1998 Nov; 82(5):727-32. PubMed ID: 9839590 [TBL] [Abstract][Full Text] [Related]
5. Telomerase activity in bladder carcinoma and its implication for noninvasive diagnosis by detection of exfoliated cancer cells in urine. Yoshida K; Sugino T; Tahara H; Woodman A; Bolodeoku J; Nargund V; Fellows G; Goodison S; Tahara E; Tarin D Cancer; 1997 Jan; 79(2):362-9. PubMed ID: 9010110 [TBL] [Abstract][Full Text] [Related]
6. Non-radioactive measurement of telomerase activity in human bladder cancer, bladder washings, and in urine. Heine B; Hummel M; Müller M; Heicappell R; Miller K; Stein H J Pathol; 1998 Jan; 184(1):71-6. PubMed ID: 9582530 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite analysis and telomerase activity in archived tissue and urine samples of bladder cancer patients. Linn JF; Lango M; Halachmi S; Schoenberg MP; Sidransky D Int J Cancer; 1997 Dec; 74(6):625-9. PubMed ID: 9421360 [TBL] [Abstract][Full Text] [Related]
8. Improvement in detecting telomerase activity using silica-based resin treatment: An experience of urine in bladder carcinoma. Yahata N; Nagao K; Ohyashiki JH; Hisatomi H; Ohyashiki K Int J Oncol; 1999 Apr; 14(4):709-12. PubMed ID: 10087318 [TBL] [Abstract][Full Text] [Related]
9. Telomerase activity in patients with transitional cell carcinoma: a preliminary study. Rahat MA; Lahat N; Gazawi H; Resnick MB; Sova Y; Ben-Ari G; Cohen M; Stein A Cancer; 1999 Feb; 85(4):919-24. PubMed ID: 10091771 [TBL] [Abstract][Full Text] [Related]
11. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma. Bian W; Xu Z Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565 [TBL] [Abstract][Full Text] [Related]
12. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR. Xie XY; Yang X; Zhang JH; Liu ZJ Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306 [TBL] [Abstract][Full Text] [Related]
14. Telomerase activity in urine sediments as a tool for noninvasive detection of bladder cancer. Dettlaff-Pokora A; Matuszewski M; Schlichtholz B Cancer Lett; 2005 May; 222(1):83-8. PubMed ID: 15837544 [TBL] [Abstract][Full Text] [Related]
15. Telomerase activity and cytokeratin 20 as markers for the detection and followup of transitional cell carcinoma: an unfulfilled promise. Cassel A; Rahat MA; Lahat N; Lindenfeld N; Mecz Y; Stein A J Urol; 2001 Sep; 166(3):841-4. PubMed ID: 11490230 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the telomeric repeat amplification protocol (TRAP) assay for telomerase as a diagnostic modality in recurrent bladder cancer. Dalbagni G; Han W; Zhang ZF; Cordon-Cardo C; Saigo P; Fair WR; Herr H; Kim N; Moore MA Clin Cancer Res; 1997 Sep; 3(9):1593-8. PubMed ID: 9815848 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of an in vitro telomeric repeat amplification protocol assay to detect telomerase activity in canine urine. McCleary-Wheeler AL; Williams LE; Hess PR; Suter SE Am J Vet Res; 2010 Dec; 71(12):1468-74. PubMed ID: 21117999 [TBL] [Abstract][Full Text] [Related]
18. Performance characteristics of multiple urinary tumor markers and sample collection techniques in the detection of transitional cell carcinoma of the bladder. Bhuiyan J; Akhter J; O'Kane DJ Clin Chim Acta; 2003 May; 331(1-2):69-77. PubMed ID: 12691866 [TBL] [Abstract][Full Text] [Related]
19. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder. Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219 [TBL] [Abstract][Full Text] [Related]
20. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]